242 House Lawmakers Oppose Part B Demo; But Consumers, Insurers Support It

Under pressure to take sides, another wave of lawmakers and lobby groups announced Monday (May 2) either their support or opposition to CMS' proposed cost-cutting demonstration to change the physician reimbursement formula for administering drugs in Medicare Part B. It is a crucial moment for the proposed demonstration because strong resistance could spur CMS to significantly change or delay the demo, and the agency's reaction could determine Congress' next step, a drug lobbyist said. A bipartisan group of 242 House...